Latest News and Press Releases

REC-4881 (4 mg QD) achieved rapid clinical activity, with 75% of evaluable patients showing reductions in total polyp burden and a 43% median reduction after 12 weeks of treatment (n=12)After 12 weeks...

Following a single subcutaneous 240 mg dose, WVE-007 (INHBE GalNAc-siRNA) improved body composition at three months compared to baseline, with a 9.4% reduction in visceral fat (p=0.02), a 4.5%...

Chicago, Dec. 08, 2025 (GLOBE NEWSWIRE) -- The Europe B2B car subscription market was valued at US$ 553.22 million in 2024 and is projected to reach USD 4,174.46 million by 2033, driven by a robust...

-- Bezuclastinib demonstrated rapid and deep clinical benefit in AdvSM patients resulting in an objective response rate (CR+CRh+PR+CI) of 57% per mIWG criteria and 80% per PPR criteria -- --...

This news release constitutes a “designated news release” for the purposes of the Company’s amended and restated prospectus supplement dated November 18, 2025, to its short form base shelf prospectus...

Following internal analysis and Data Monitoring Committee (DMC) feedback, the Company has elected to discontinue the BX004 Cystic Fibrosis (CF) Phase 2b trial  BiomX continues to see potential in...

All amounts in U.S. dollars unless otherwise stated  TORONTO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Onex Corporation (“Onex”) (TSX: ONEX) today announced that it has sold approximately 4.1 million...

NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Gemini Space Station, Inc. (Gemini) (NASDAQ: GEMI) today announced that Marshall Beard, Chief Operating Officer, and Dan Chen, Chief Financial Officer,...

CLEVELAND, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced the first commercial patient treatment with FDA-approved ZEVASKYN (prademagene zamikeracel), a...

LOUISVILLE, Ky., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Stock Yards Bancorp, Inc. (NASDAQ: SYBT), parent company of Stock Yards Bank & Trust Company, with offices in the Louisville, central, eastern...